MMIT Announces Sixth-Annual Specialty Pharmacy Patient Choice Awards
03 août 2021 09h00 HE
|
Managed Markets Insight & Technology, LLC
Yardley, PA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that...
Exclusive AIS Health Enrollment Data Shows Which Plans Gained During the Medicare Open Enrollment Season
03 juin 2021 13h00 HE
|
AIS Health, an MMIT company
Washington, DC, June 03, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage enrollment grew just 1% during the recent 2021 Open Enrollment Period that ran from January to March, compared with growth of 7%...
MMIT & The Dedham Group Unite to Smooth Access to Therapy
27 avr. 2021 07h00 HE
|
Managed Markets Insight & Technology, LLC
Yardley, PA, April 27, 2021 (GLOBE NEWSWIRE) -- Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to- market partner solely focused on solving the “what and why” of market...
Syneos Health Communications Bolsters Value, Access and Public Affairs Offerings with Key Senior Hires
23 févr. 2021 09h51 HE
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...
Regenerative Medicine in Pharma 2020 - Opportunities, Challenges, and Unmet Needs
23 déc. 2020 02h33 HE
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "Regenerative Medicine in Pharma - Thematic Research" report has been added to ResearchAndMarkets.com's offering. Regenerative medicine is a...
Real Endpoints Launches the First Turn-Key Platform for Value-Based Contracting
09 déc. 2020 10h45 HE
|
Real Endpoints
The RE Marketplace established with four founding health plans representing nearly 2.5 million lives. Each plan and its beneficiaries get immediate access to contracts for all biotech drugs in the...
Real Endpoints Strengthens and Broadens Access Capabilities and Reach with the Hiring of Key Executive
10 nov. 2020 14h30 HE
|
Real Endpoints
FLORHAM PARK, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Real Endpoints (RE), a leading boutique life science consultancy focused on market access, today announced it has hired Robert O’Brien as Vice...
Digital therapeutics executive Jeffrey Abraham joins Health Advances, bolstering the firm’s industry-leading digital health practice
19 août 2020 09h00 HE
|
Health Advances, LLC
NEWTON, Mass., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Health Advances, a global leader in commercial strategy in life sciences, technology, and digital health, today announced the appointment of Jeffrey...
RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National Formulary
28 avr. 2020 07h00 HE
|
RedHill Biopharma Ltd.
Talicia® is the first and only FDA-approved rifabutin-based therapy for H. pylori infection, designed as a first-line option to address the high resistance of H. pylori bacteria to standard-of-care...
Real Endpoints’ Susan Raiola Named to 2019 PharmaVoice 100
06 août 2019 09h00 HE
|
Real Endpoints
MADISON, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Real Endpoints (RE), an advisory and analytics firm entirely focused on enhancing appropriate access to healthcare innovation, announced today that...